MICROSATELLITE-STABLE COLORECTAL CANCER
Clinical trials for MICROSATELLITE-STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE-STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE-STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a combination of two drugs (NT-I7 and pembrolizumab) in 215 adults with advanced solid tumors that had come back or stopped responding to standard treatments. The goal was to find a safe dose and see if the combo could shrink tumors. The study also looked at imm…
Matched conditions: MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for advanced colon cancer: immune drugs shrink tumors in biomarker-positive patients
Disease control CompletedThis study tested the drug nivolumab, alone or with other cancer drugs, in 385 people whose colon cancer had returned or spread. It focused on patients with a specific genetic marker called MSI-H. The goal was to see if the treatment could shrink tumors. While not a cure, the app…
Matched conditions: MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 04, 2026 16:18 UTC